Introduction
Hypertension, currently defined as an average systolic blood pressure (SBP) у140 and/or a diastolic blood pressure (DBP) у90 mm Hg based on multiple blood pressure recordings or treatment with antihypertensive drugs, 1,2 is one of the most common and powerful risk factors for cardiovascular diseases (CVD). 3 Isolated systolic hypertension (ISH) is defined as SBP у140 mm Hg and DBP Ͻ90 mm Hg. 1, 2 In most epidemiological studies, where multiple recordings are usually not possible, ISH has been defined as SBP у160 mm Hg in the presence of DBP of either less than 90 or 95 mm Hg. ISH has been associated with increased cardiovascular mortality and morbidity not only in the elderly 4, 5 but also in middle-aged persons, [6] [7] [8] [9] [10] [11] and a SBP level of 140-159 mm Hg already seems to increase the risk of CVD. 12, 13 The prevalence of ISH increases in both sexes with age.
14 However, population-based data on the secular trends in ISH are notably scarce.
Over the past 20 years, the follow-up of the North Karelia Project and the MONICA project have demonstrated a reduction in SBP and DBP in middle-Subjects on antihypertensive medication were classified as having diastolic hypertension. The prevalence of isolated systolic hypertension increased in both sexes and in all age groups except among the youngest women, whereas the prevalence of diastolic hypertension decreased. The proportion of subjects with isolated systolic hypertension out of all hypertensive subjects increased from 11% in 1972 to 24% in 1992 among men and from 15% to 27% among women. The overall decrease in blood pressure, particularly the disproportionate decrease in diastolic over systolic blood in mean pressure may have resulted in the increase in the prevalence of isolated systolic hypertension.
aged subjects in eastern Finland. 15, 16 The application of standardised methods in a well-defined population with cross-sectional data from five surveys of the North Karelia Project and the FINMON-ICA study gave us a unique opportunity to study the secular trends in ISH over a 20-year period. The aim of this study is to describe the trends in the prevalence of ISH, diastolic hypertension (DHT) and the proportion of normotensive persons (NT) among middle-aged men and women during 1972 to 1992.
Materials and methods
Since 1972 independent cross-sectional population surveys have been drawn from the population register every 5 years to assess the levels of CVD risk factors in the provinces of North Karelia 19 and comparable to the methods used in 1972 and 1977. The details of the survey methods have been described earlier. 17 Briefly, the participants were sent in advance a self-administered questionnaire including questions about medical history and health behaviour. The people who reported having taken antihypertensive drugs during the preceding week of the survey were classified as being under antihypertensive treatment. For the survey, specially trained nurses measured the casual blood pressure of the subjects according to standardised procedures. Blood pressure was measured using a standard sphygmomanometer from the right arm of the subject, who had been seated for 5 The sample sizes and the number of subjects in the five surveys, classified into the blood pressure groups according to their measured casual blood pressure levels by age group, are presented in Table 1 . During the study period there were 128 men Table 1 Number of men and women in specified blood pressure groups by age group, 1972-1992
Study year
Men Women 1972 Women 1977 Women 1982 Women 1987 Women 1992 Women 1972 Women 1977 Women 1982 Women 1987 Women 1992 and 355 women with ISH and 352 normotensive men and 581 normotensive women, who were forced into the DHT group because of the use of antihypertensive medication. The prevalences of ISH, DHT and NT as well as their means of systolic and diastolic blood pressures were calculated separately in the age groups of 30-49 years, 50-59 years, 60-64 years and in all age groups combined. In addition, we determined the proportions of subjects with ISH out of all hypertensive subjects using as the denominator the subjects with DBP у95 mm Hg and those with SBP у160 mm Hg and subjects with antihypertensive medication by sex and age-group. Database management was performed using the Statistical Analysis System (The SAS Institute Inc, Cary, NC, USA). The secular trends in ISH prevalence were analysed by the chi-square test for trend of proportions. 20 Since the change in the size of the cuff bladder between 1977 and 1982 had an influence on the measured blood pressure level, the trends in hypertension during 1982 to 1992 were also analysed separately. In each study year, the agestandardised prevalences were calculated by the direct method for the entire group aged 30-64 years in each study year (for 1972, 30-59 years) using the entire study population as a reference population.
Results
In 1992, the prevalence of ISH among all men was 8.2%, and it rose from 5.4% among men aged 30-49 years to 17.1% among men aged 60-64 years (Table 2a ). The prevalence of ISH was 7.4% among all women, and it rose from 2.7% in the age group of 20-49 years to 17.5% in the age group of 60-64 years (Table 2b ). The age-standardised overall prevalence of ISH was 7.5% among men and 6.9% among women.
The prevalence of ISH increased significantly during the study period from 1972 to 1992 in every age group, except among the youngest women aged 30-49 years. The lowest proportions of ISH in both sexes were seen in 1977. During 1982 to 1992, the trend in the prevalence of ISH remained relatively stable in all age groups among men and also among women aged 50-59 years and 60-64 years, while among all women and among women aged 30-49 years it decreased slightly. In 1992, the age-standardised prevalence of DHT was 25.3% among all men and 19.3% among all women. From 1972 to 1992, the age group-specific prevalence of DHT declined statistically significantly in both sexes. The relative decrease in the overall age-standardised prevalence of DHT was 36.2% among men and 49.7% among women. The prevalence of DHT also decreased during 1982 to 1992 and the decrease was statistically non-significant only among men aged 60-64 years.
The overall age-standardised proportion of NT men increased from 55.6% in 1972 to 67.2% in 1992 (relative increase 20.9%) and that of NT women from 55.0% to 73.8% (relative increase 37.2%), respectively. The increasing trend in NT was statistically significant in all age sub-groups among women, but in only the youngest age group of men. During 1982 to 1992, the prevalence of NT among men aged 50-59 years also increased statistically significantly.
The proportion of persons with ISH out of all hypertensive subjects and out of the patients on antihypertensive medication increased during the study period in all age groups and in both sexes (Figure 1) . The overall change from 1972 to 1992 was from 11% to 24% among all hypertensive men and from 15% to 27% among all hypertensive women. In the 1972 survey 10% of all hypertensive men and 14% of all hypertensive women aged 30-49 years had ISH, whereas in the 1992 survey the proportions of ISH were 22% and 20%, respectively. The corresponding 20-year changes were from 11% to 21% among men and from 15% to 27% among women aged 50-59 years and 15-year changes from 15% to 32% among men and from 11% to 34% among women aged 60-64 years.
The entire population exhibited a 4 mm Hg fall in SBP and an 8 mm Hg fall in DBP among men, and a 12 mm Hg fall in SBP and DBP among women during the 20-year period ( Table 3 ). The corresponding decreases of SBP among men and women were 6 mm Hg and 12 mm Hg in the age group of 30-49 years and 7 mm Hg and 17 mm Hg in the age group of 40-59 years. Among women aged 60-64 years SBP decreased by 6 mm Hg, but in the men of this age group, the SBP level did not change at all. The decrease in DBP among men varied from 6 mm Hg in 60 to 64-year-olds to 9 mm Hg in 30 to 49-yearolds and among women from 10 mm Hg in 60 to 64-year-olds mm Hg to 14 mm Hg in 50 to 59-yearolds, respectively.
Discussion
The average blood pressure level in Finland has been found to be higher than in most other populations. 21 In the first survey of our study in 1972, which did not comprise subjects aged 60-64 years, the overall prevalence of ISH was 4.7% among men and 6.6% among women and that of DHT 39.8% among men and 38.4% among women, respectively. The prevalence of ISH increased with age in both sexes. The 1972 survey served as the baseline survey of the North Karelia Project. 17 One of the aims of this comprehensive community-based intervention programme was to shift downward the population levels of major CVD risk factors. In past 20 years, decreases in SBP and DBP have been reported among both men and women in eastern Finland. 15, 16 The present study showed a decrease in the mean SBP and DBP during the study period, except among men aged 60-64 years. The decline in the prevalence of DHT over the study years was statistically significant in all age groups and in both sexes, except in men aged 50-59 years. The largest relative decrease in DHT prevalence was found in the youngest age group, and it was slightly larger in women than in men. More women than men in all age groups had normotensive blood pressure values in 1992.
Since the mean levels of both SBP and DBP and 489 Previous epidemiological reports have focused on cross-sectional ISH data of but the study protocols have not been uniform, making formal comparisons difficult. The prevalence of ISH depends on the diastolic and systolic cut-off points, and it varies according to the sex, race, geographic location, number of blood pressure measurements recorded, treatment status and age distribution of the population studied.
14 In a meta-analysis the prevalence of ISH increased from 3% at the age of 30 years to 5% at 60 years, 13% at 70 years and 23% at 80 years. 14 In the British Regional Heart Study the prevalence of ISH with a DBP level Ͻ90 mm Hg was 8% among men aged 40-59 years. 22 The other studies that have determined the prevalence of ISH among middleaged men and women in the population have usually reported lower estimates than ours. [8] [9] [10] [11] 23, 24 Since different methods have been used, the comparisons of prevalence estimates must, however, be interpreted with caution.
The findings from a few previous studies on secular trends in ISH prevalence have been inconclusive. One of the main reasons for this is that they have not been based on repeated surveys of defined populations with consistent methods. An analysis of the secular trend in the prevalence of ISH in the Framingham Heart Study did not show much variation in ISH over time. The prevalence was 4% in 1950, 6% in 1960 and 6% in 1970 (P Ͼ 0.10 for trend) among men and 9%, 8% and 9% (P Ͻ 0.10) among women aged 50-59 years. 24 The Framingham study is a cohort study, which is not ideal for trend assessment in the community. Between the first National Health Examination Survey I (NHES I, 1960 (NHES I, -1962 and the National Health Examination and Nutrition Survey I (NHANES I 1971 (NHANES I -1974 , as well as between 1967-1969 and 1981 in Georgia in the United States, 25 the ISH prevalence decreased among middle-aged men and women. In these studies both treated and untreated hypertensive subjects were included in all ISH categories, and thus a fraction of the treated subjects with ISH at the time of the survey probably comprised persons who originally had not ISH but DHT with a selective lowering of DBP. The findings from the few trend analyses of ISH prevalence among the elderly thus far reported have also been inconsistent. 25, 26 The prevalences of ISH and DHT combined, including treated hypertensive subjects, have been lower in other populations than in the present study, but the secular trends have been not too different from ours. In the NHANES I in 1971-1974 and two subsequent cross-sectional cohorts in the US population in 1976-1980 and 1988-1991 the prevalences were 20%, 21% and 14%, respectively, among white men and 18%, 17% and 13%, respectively, among white women aged 18-74 years. 27 In three Swedish surveys using consistent methods the prevalence of DHT and ISH combined among men aged 50 years was 37% in 1973, 14% in 1983 and 17% in 1993. 28 In two different Belgian populationbased studies, the age-standardised prevalence among men aged 25-64 years was 20% in 1980-1984 and 13% in 1985-1992 (P Ͻ 0.001) and the values among women were 19% and 13% (P Ͻ 0.001), respectively. 29 The prevalence of ISH and DHT combined in Israel decreased between 1970 and 1986 from 36% to 29% (P Ͻ 0.005) among men and from 43% and to 35% (P Ͻ 0.0001) among women aged 50 years or more. 30 Several factors might contribute to the difference in trends between ISH and DHT in the present analysis. Compared to repeat measurements of blood pressure, analyses based on single blood pressure measurements only lead to an overestimation of the prevalence of DHT only. The effect on the prevalence of ISH is not equivocal, since after repeat blood pressure measurements some of the subjects with ISH will shift to the normotensive group, while in turn some of the subjects with DHT will become classified as ISH. The use of antihypertensive drug treatment makes it difficult to estimate the trends in the true prevalence of hypertension and particularly its subcategories. The guidelines for drug treatment of hypertension in Finland in the 1970s and the 1980s used mainly DBP values as the treatment criteria. In 1994, for the first time in Finland, the national management guidelines on hypertension recommended drug treatment for a DBP level of less than 90 mm Hg in elderly patients whose SBP level was permanently у160 mm Hg, if non-pharmacological treatment was not effective. In view of the above-mentioned guidelines, our strategy is valid in considering only such individuals who were not on antihypertensive medication as having ISH in the surveys carried out in 1992 or earlier. The cuff length was longer than previously in the 1982 survey. SBP was found to be 4 mm Hg lower and DBP 5 mm Hg lower when measured with the long cuff than with the short cuff. 31 This may have caused an overestimation of the proportion of normotensive subjects and an underestimation of the proportion of DHT in 1982, 1988 and 1992 compared to the earlier surveys, where a shorter cuff was used. The effect of this change in the cuff size on the prevalence of ISH from 1977 to 1982 remains unclear.
The proportion of subjects on antihypertensive drug treatment markedly increased during 1972 to 1982. 31 However, drug treatment only explains part of the decline of blood pressure level in the entire population. In the 1970s, non-pharmacological treatment of hypertension was not practised at all in Finland. In the 1980s, non-pharmacological recommendations were primarily targeted to the individuals with DHT.
Non-pharmacological interventions, such as an increased use of polyunsaturated fats and a decrease in salt consumption, might have contributed to a change in blood pressure in Finland. 15 Especially in men, the disproportionate decrease in DBP (8 mm Hg) over SBP (4 mm Hg) in the present study may have resulted in a shift towards to a higher prevalence of ISH among untreated hypertensive subjects. In an overview of randomised trials, Cutler et al 32 showed a statistically significant effect of the reduction of sodium intake on SBP in hypertensive and normotensive subjects. 32 The more active application of these strategies to subjects with ISH had possibly produced a fall in the prevalence of ISH among untreated hypertensive subjects.
Shifting part of the people with previous DHT into the category of ISH, 'a burned-out DHT', might also be a consequence of an increasing awareness of high blood pressure and more frequent blood pressure measurements within the population, which may lead to a resolution of 'white coat hypertension' or 'regression towards the mean' in DBP. 33 An increase of arterial stiffening resulting in a fall of DBP and an increase in ISH prevalence, however, appears to be an unlike explanation in middle-aged untreated persons.
In conclusion, the prevalence of DHT has decreased during the 20 study years in Finnish middle-aged men and women, whereas the prevalence of ISH has not decreased, but probably increased. The proportion of subjects with ISH out of all hypertensive patients has doubled in 20 years. Women in the age sub-group of 30-49 constitute an exception in this respect years, as their prevalence of ISH has fallen and is now lower than that in men. In 1992, for the first time, the proportion of normotensive women exceeded that of normotensive men in all age groups. Assuming the tracking phenomenon in blood pressure levels, 34 this might predict a lower prevalence of ISH also in middle-aged women. Since hypertension generally occurs in combination with other risk factors such as obesity, it will also be necessary to determine the changes in the other risk factor possibly associated with changes in the prevalence of ISH.
